Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
12:57 pm
Purchase
13GTRACON Pharmaceuticals, Inc.
TCON
Ikarian Capital LLC2,765,530
12.5%
74,420increase
(+2.77%)
View
2023-02-14
11:26 am
Sale
13GX4 Pharmaceuticals, Inc.
XFOR
Ikarian Capital LLC349,133
0.3%
-1,915,358decrease
(-84.58%)
View
2023-02-14
11:03 am
Sale
13GMilestone Pharmaceuticals Inc.
MIST
Ikarian Capital LLC460,416
1.3%
-1,289,627decrease
(-73.69%)
View
2023-02-14
11:02 am
Sale
13GBellicum Pharmaceuticals, Inc.
BLCM
Ikarian Capital LLC448,101
5.2%
-48,655decrease
(-9.79%)
View
2022-02-14
4:43 pm
Sale
13GX4 Pharmaceuticals, Inc.
XFOR
Ikarian Capital LLC2,264,491
8.1%
-360,497decrease
(-13.73%)
View
2022-02-14
4:41 pm
Sale
13GaTyr Pharma, Inc.
LIFE
Ikarian Capital LLC35,048
0.1%
-853,532decrease
(-96.06%)
View
2022-02-14
4:39 pm
Sale
13GProtara Therapeutics, Inc.
TARA
Ikarian Capital LLC279,256
2.5%
-370,286decrease
(-57.01%)
View
2022-02-14
4:37 pm
Sale
13GTRACON Pharmaceuticals, Inc.
TCON
Ikarian Capital LLC2,691,110
13.8%
-25,730decrease
(-0.95%)
View
2022-02-14
4:36 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
Ikarian Capital LLC1,750,043
5.9%
-86,502decrease
(-4.71%)
View
2022-02-14
4:36 pm
Sale
13GOdonate, Inc.
ODTC
Ikarian Capital LLC1,340,631
3.5%
-645,781decrease
(-32.51%)
View
2022-02-14
4:35 pm
Sale
13GscPharmaceuticals Inc.
SCPH
Ikarian Capital LLC901,362
3.3%
-564,785decrease
(-38.52%)
View
2022-02-14
4:34 pm
Sale
13GScience 37 Holdings, Inc.
SNCE
Ikarian Capital LLC0
0%
-512,450decrease
(Position Closed)
View
2022-02-14
4:34 pm
Sale
13GCyclacel Pharmaceuticals, Inc.
CYCC
Ikarian Capital LLC99,422
1%
-300,578decrease
(-75.14%)
View
2022-02-14
4:32 pm
Sale
13GBellicum Pharmaceuticals, Inc.
BLCM
Ikarian Capital LLC496,756
5.9%
-3,244decrease
(-0.65%)
View
2022-02-14
4:32 pm
Sale
13GKalVista Pharmaceuticals, Inc.
KALV
Ikarian Capital LLC36,576
0.2%
-1,027,385decrease
(-96.56%)
View
2022-02-14
4:31 pm
Sale
13GTempest Therapeutics Inc.
MLND
Ikarian Capital LLC58,803
0.9%
-1,289,218decrease
(-95.64%)
View
2022-02-14
4:30 pm
Sale
13GLyra Therapeutics, Inc.
LYRA
Ikarian Capital LLC394,536
3%
-420,828decrease
(-51.61%)
View
2021-09-17
3:00 pm
Purchase
13GaTyr Pharma, Inc.
LIFE
Ikarian Capital LLC888,580
5.3%
888,580increase
(New Position)
View
2021-07-02
4:05 pm
Purchase
13GOdonate, Inc.
ODTC
Ikarian Capital LLC1,986,412
5.2%
1,986,412increase
(New Position)
View
2021-04-08
09:02 am
Purchase
13GX4 Pharmaceuticals, Inc.
XFOR
Ikarian Capital LLC2,624,988
11.1%
1,798,564increase
(+217.63%)
View
Goto 0, 1, 2, Next